Vaccine distribution help on the way from Google

Google Cloud has launched an AI-backed technology toolkit to help government health personnel direct COVID vaccine doses and other resources where they’re most needed.

Called Intelligent Vaccine Impact, the software suite also has components to help inform, schedule, vaccinate and reassure residents at the local and regional levels.

Google announced the offering this month in a blog post.

For the vaccine distribution component, the company developed a machine learning approach combining AI with epidemiology data and an AI-driven “what if” modeling tool. The latter is designed to prepare health teams for various possible scenarios.

“Using a unique set of Looker dashboards, state epidemiologists and public health professionals can now aggregate the results of these [‘what if’] models … with both public and private datasets to drive better policy decisions,” writes Google Cloud VP Mike Daniels. “Government leaders can then see how the forecasts change in response to policy changes.”

Daniels says Intelligent Vaccine Impact is also intended to broaden vaccine availability while extending “equitable access to those who need it.”

The suite is designed to readily integrate with a wide range of existing technologies, Daniels notes.

Read the rest.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.